An adaptive Phase 2 randomized double-blind, placebo controlled multi-center study to evaluate the safety and efficacy of multiple LOU064 doses in patients with moderate to severe Sjögren’s Syndrome (LOUiSSe)

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/19/CALHN/226
NMA SSA Reference Number: SSA/58192/MonH-2019-190027(v1)
Monash Health Ref: RES-19-0000-761X
Effective start/end date18/10/1917/10/24


  • clinical trial
  • Sjögren’s Syndrome
  • treatment efficacy
  • phase 2 study